Suppr超能文献

相似文献

1
Cardiac hypertrophy: stressing out the heart.
J Clin Invest. 2006 Jun;116(6):1467-70. doi: 10.1172/JCI28884.
5
β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway.
Cardiovasc Res. 2012 Nov 1;96(2):255-64. doi: 10.1093/cvr/cvs249. Epub 2012 Jul 27.
9
Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
Clin Exp Pharmacol Physiol. 2007 Apr;34(4):255-62. doi: 10.1111/j.1440-1681.2007.04585.x.

引用本文的文献

1
USP20 deletion promotes eccentric cardiac remodeling in response to pressure overload and increases mortality.
Am J Physiol Heart Circ Physiol. 2024 Nov 1;327(5):H1257-H1271. doi: 10.1152/ajpheart.00329.2024. Epub 2024 Oct 4.
2
Differential roles of eosinophils in cardiovascular disease.
Nat Rev Cardiol. 2025 Mar;22(3):165-182. doi: 10.1038/s41569-024-01071-5. Epub 2024 Sep 16.
3
Downregulation of PTEN Promotes Autophagy Concurrent Reduction in Apoptosis in Cardiac Hypertrophy in PPAR α Mice.
Front Cardiovasc Med. 2022 Feb 11;9:798639. doi: 10.3389/fcvm.2022.798639. eCollection 2022.
4
ATF3 expression in cardiomyocytes and myofibroblasts following transverse aortic constriction displays distinct phenotypes.
Int J Cardiol Heart Vasc. 2020 Dec 29;32:100706. doi: 10.1016/j.ijcha.2020.100706. eCollection 2021 Feb.
5
Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player.
ESC Heart Fail. 2020 Aug;7(4):1488-1501. doi: 10.1002/ehf2.12728. Epub 2020 May 18.
7
The Hippo Signaling Pathway in Cardiac Development and Diseases.
Front Cell Dev Biol. 2019 Oct 1;7:211. doi: 10.3389/fcell.2019.00211. eCollection 2019.
9
GRK5 - A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders.
Front Pharmacol. 2018 Dec 17;9:1484. doi: 10.3389/fphar.2018.01484. eCollection 2018.

本文引用的文献

2
Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice.
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18219-24. doi: 10.1073/pnas.0509181102. Epub 2005 Dec 2.
3
Left ventricular size and shape: determinants of mechanical signal transduction pathways.
Heart Fail Rev. 2005 Jun;10(2):95-100. doi: 10.1007/s10741-005-4636-y.
4
Protein kinase cascades in the regulation of cardiac hypertrophy.
J Clin Invest. 2005 Mar;115(3):527-37. doi: 10.1172/JCI24178.
5
Prognostic significance of left ventricular mass change during treatment of hypertension.
JAMA. 2004 Nov 17;292(19):2350-6. doi: 10.1001/jama.292.19.2350.
7
Network integration of the adrenergic system in cardiac hypertrophy.
Cardiovasc Res. 2004 Aug 15;63(3):391-402. doi: 10.1016/j.cardiores.2004.03.011.
8
Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Circ Res. 2004 Jan 9;94(1):110-8. doi: 10.1161/01.RES.0000109415.17511.18. Epub 2003 Dec 1.
10
Compensatory hyperfunction of the heart and cardiac insufficiency.
Circ Res. 1962 Mar;10:250-8. doi: 10.1161/01.res.10.3.250.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验